Mechlorethamine: Clinical Trials

4 trials of Mechlorethamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed, 1 unknown. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Active not recruiting 2, Completed 1, Unknown 1

Follow Mechlorethamine: new trials by email Literature Review of Mechlorethamine trials Research Report on Mechlorethamine

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma
bleomycin sulfate, ABVD regimen, Stanford V regimen - Lymphoma
Phase 3UnknownMount Vernon Cancer Centre at Mount Vernon Hospital8502001-10-012013-09-20
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Doxorubicin, Bleomycin, Vinblastine - Lymphoma
Phase 3CompletedEastern Cooperative Oncology Group8541999-06-172023-06-29
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
bleomycin sulfate, doxorubicin hydrochloride, mechlorethamine hydrochloride - Lymphoma
Phase 3Active not recruitingEuropean Organisation for Research and Treatment of Cancer - EORTC11581993-09-012025-08-05
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
bleomycin sulfate, doxorubicin hydrochloride, mechlorethamine hydrochloride - Lymphoma
Phase 3Active not recruitingEuropean Organisation for Research and Treatment of Cancer - EORTC6151989-09-012025-08-05

Conditions studied

Hodgkin Disease (4)  ·  Lymphoma (4)

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Eastern Cooperative Oncology Group (1)  ·  Mount Vernon Cancer Centre at Mount Vernon Hospital (1)

Countries

Belgium (1)  ·  Canada (1)  ·  Egypt (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Portugal (1)  ·  Slovenia (1)  ·  South Africa (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Christophe Ferme (1)  ·  H. Eghbali, MD (1)  ·  John Raemaekers, MD, PhD (1)  ·  Peter J. Hoskin, MD (1)  ·  Sandra J. Horning, MD (1)

Results publications

PMID 15936157, PMID 17097834, PMID 17989384, PMID 19828373, PMID 23182987, PMID 23356491, PMID 23386127, PMID 25897153, PMID 9187443

NIH funding

U10CA021115 (1)